A new discovery in regenerative medicine
IMAGE: In vitro culture of induced trophoblast stem cells (pink) wrapping clusters of naive induced pluripotent
IMAGE: In vitro culture of induced trophoblast stem cells (pink) wrapping clusters of naive induced pluripotent
Stanford Medicine researchers are investigating whether a combination of specific antibodies can reduce early symptoms
The MarketWatch News Department was not involved in the creation of this content. Sep 17,
AMSTERDAM, Sept. 16, 2020 /PRNewswire/ — Adyen (AMS: ADYEN), the global payments platform of choice
The MarketWatch News Department was not involved in the creation of this content. Sep 21,
Singapore, 22 September 2020 – Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an interdisciplinary
GRAFTON – It has long been established that birds of prey have been ingesting poison
The MarketWatch News Department was not involved in the creation of this content. Sep 21,
DUBLIN, Sept. 22, 2020 /PRNewswire/ — The “Global Liquid Biopsy Market (by Circulating Biomarker, Product,
Bioenergetics is a form of psychodynamic psychotherapy that combines healing the mind as well as the body. Its aim
TipRanks Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 50% Is
Sept. 11, 2020 BRANCHBURG, NJ – Residents can safely dispose of their unwanted and outdated
PHILADELPHIA — Golnaz Vahedi, PhD, an assistant professor of Genetics in the Perelman School of
Sarah Nelson | The Gainesville Sun Some employees at the University of Florida’s Shands Hospital and
Below please find a summary and link(s) of new coronavirus-related content published today in Annals
CLOSE Debt collectors representing the IRS may be calling. Here’s how to know that it’s
The MarketWatch News Department was not involved in the creation of this content. Sep 11,
By UW Medicine | Newsroom The immune system usually mounts a strong immune response to
The MarketWatch News Department was not involved in the creation of this content. Sep 01,
CARLSBAD, Calif., Sept. 2, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced the publication today